June 5, 2003) , MDS Pharma Services
, a leading provider of innovative drug discovery and development solutions, has named Vincent J. Andaloro
, Ph.D., as clinical site director of its early clinical research facility in Phoenix, Ariz., announced Jerry Merritt, Pharm.
..."Dr. Andaloro's unique mix of scientific competencies and interpersonal skills will serve him well in this position since, in addition to interacting with our clients and ensuring that MDS Pharma Services meets or exceeds their expectations, he will also manage the quality and efficiency of the site, identify physician resources and build relationships with the community," said Robert A. Earl, Ph.D., senior director, Clinical Operations, USA.
...Andaloro joined the company in 2001 and previously served as director of Method Development and Validation at MDS Pharma Services' early clinical research and bioanalysis facility in Lincoln, Nebraska.His clinical therapeutic experience includes rheumatoid arthritis, lupus and other autoimmune diseases; cancer, neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease; diabetes, atherosclerosis, psychiatric disorders and metabolic diseases.Dr. Andaloro has a bachelor's degree in Chemistry from Clark University in Worcester, Mass., and earned his doctorate in Pharmacology at the University of Florida College of Medicine in Gainesville.He served as a postdoctoral fellow at the University of Nebraska Medical Center in Omaha before joining MDS Pharma Services.